The positive correlation of LIFR (Leukemia Inhibitory Factor Receptor), which is known to be highly expressed in multiple malignancies, with immune cells such as neutrophils, T cells, gamma, follicular helper T cells, regulatory T cells, resting mast cells, and naïve B cells, highlights its potential immunomodulatory role in ARVC [29]. Here, LIFR is linked to arrhythmogenic right ventricular cardiomyopathy.